DNA And Gene Chip Market Insights 2025-2034: Growth Dynamics, Trends, and Strategic Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What are the Key Projections for the CAGR of the DNA And Gene Chip Market From 2025 to 2034?
The market size for DNA and gene chips has seen a speedy expansion in the last few years. The market is projected to increase from $8.19 billion in 2024 to $9.27 billion in 2025, with a compound annual growth rate (CAGR) of 13.1%. The surge in the historic period can be accredited to the progression in genomic research, the emergence of personalized medicine, milestones achieved in the human genome project, breakthroughs in drug discovery and development, along with disease biomarker identification.
Predictions for the DNA and gene chip market project a speedy acceleration in size over the upcoming years, swelling to an estimated $15.35 billion by 2029, following a compound annual growth rate (CAGR) of 13.4%. This predicted growth in the forecast period can be linked to strides forward in precision medicine, the widening of biomarker discovery, expansion in the field of personalized therapeutics, and its application in cancer research, in addition to increased research funding. Key trends forecasted for this period consist of technological advancements, innovative products, adherence to regulatory framework, focus on rare diseases, and a steady decline in costs.
What Strategic Factors Are Influencing the Accelerated Growth of the dna and gene chip Market?
The escalating need for early detection of cancer is playing a pivotal role in driving the growth of the DNA and gene market. The term ‘cancer’ covers a wide range of diseases which can occur in virtually any tissue or organ in the body. They are characterised by abnormal cells that reproduce uncontrollably, violating normal cell boundaries to invade neighbouring organs, and metastasizing to other parts of the body. DNA and gene chips come into play to study gene expression patterns, establish the genetic and epigenetic landscape, and assess genomic regulatory elements adhered to by cancer transcription factors in cancerous cells. For example, the American Cancer Society, a community-based voluntary health organization in the United States, anticipates that in 2022 about 1.9 million new cancer cases will be diagnosed and 609,360 death cases will be due to cancer. Hence, the burgeoning demand for early cancer screening is fueling the expansion of the DNA and gene chip sector.
Request Your Free DNA And Gene Chip Market Report Sample Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=8205&type=smp
What Are the Key Industry Players Leading the Charge in the DNA And Gene Chip Market’s Growth?
Major companies operating in the DNA and gene chip market are:
• PerkinElmer Inc._x000D_
• Illumina Inc._x000D_
• Thermo Fisher Scientific Inc._x000D_
• Macrogen Inc._x000D_
• Agilent Technologies Inc._x000D_
How Are Market Trends and Shifts Impacting the Growth Trajectory of the DNA And Gene Chip Market?
Strategic alliances and collaborations are becoming increasingly prevalent in the DNA and gene chip market. Many firms in this sector are on the lookout for partnerships to consolidate their market presence. For example, Avesthagen Limited, an Indian integrated systems biology platform firm, established a four-year strategic alliance with Wipro Limited, an Indian IT firm, in June 2022. This collaboration enables both companies to undertake a project titled Cancer Risk Assessed by NGS profiling of circulating free DNA and RNA for lung cancer project-related genomics sequencing services. Moreover, in May 2022, Thermo Fisher Scientific, a US-based provider of analytical tools, collaborated with the Qatar Genome Program (QGP), part of Qatar Foundation (QF), to create an Axiom custom genotyping array for pan-Arab populations using whole-genome sequencing data from 19 Arab countries. The aim of the array, featuring 800,000 variants, is to bolster genomic research into conditions like diabetes, cardiovascular diseases, autism, and cancer. This partnership aligns with Qatar’s national vision of enhanced population health and propelling precision medicine for people with Arab origins globally. The Axiom microarray technology from Thermo Fisher augments the drive towards fast-tracked precision medicine initiatives.
Pre-order Your Report for Quick and Easy Delivery!
https://www.thebusinessresearchcompany.com/report/dna-and-gene-chip-global-market-report
How Are Key Segments Defining the Competitive Landscape of the DNA And Gene Chip Market?
The DNA and gene chip market covered in this report is segmented –
1) By Type: Oligonucleotide DNA (o-DNA), Complementary DNA (c-DNA), Other Types
2) By Application: Cancer Diagnostics, Gene Expression, Proteomics, Genomics, Drug Discovery, Agrigenomics, Other Applications
3) By End User: Academic And Government Research Institutes, Biotechnology And Pharmaceutical Companies, Hospitals And Diagnostics Centers, Other End Users
Subsegments:
1) By Oligonucleotide DNA (o-DNA): Custom Oligonucleotide Chips, Commercial Oligonucleotide Arrays
2) By Complementary DNA (c-DNA): cDNA Microarrays, cDNA Expression Arrays
3) By Other Types: Single-Cell RNA Sequencing Chips, SNP (Single Nucleotide Polymorphism) Chips, Whole Genome Amplification Chips
What Regions Are Influencing the Dynamics of the DNA And Gene Chip Market?
North America was the largest region in the DNA and gene chip market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA and gene chip market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Is the Scope and Reach of the DNA And Gene Chip Market Defined?
A DNA and gene chip is a microchip that contains microscopic DNA probes attached to a solid surface that can identify DNA from test samples and make up half of the DNA double helix. If the test sample of DNA has the mutation, then the DNA will not bind properly to the sequence on the chip. The DNA and gene chip is used to measure the expression levels of genes or to ascertain whether a particular person’s DNA has mutations in genes which are variations in DNA which can cause ailments.
Browse Through More Similar Reports By The Business Research Company:
5G Services Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/5g-services-global-market-report
5G Infrastructure Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/5g-infrastructure-equipment-global-market-report
Cellular or Mobile Telephone Services Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
